Skip to main content
Top
Published in:

Open Access 01-12-2024 | Type 2 Diabetes | Research

The relationship of dietary omega-3 fatty acid and omega-6 to omega-3 ratio intake and likelihood of type 2 diabetes in a cross-sectional study

Authors: Ebrahim Shakiba, Yahya Pasdar, Farzaneh Asoudeh, Farid Najafi, Amir Saber, Mohammad Hossein Shakiba, Amir Bagheri

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

There is a belief that consuming a significant amount of omega-3 and omega-6 fatty acids can positively affect chronic diseases. However, the connection between these fatty acids and type 2 diabetes mellitus (T2DM) risk remains unclear. To explore this further, we conducted a study to investigate the relationship between dietary intake of omega-3 and omega-6 fatty acids (FA), as well as omega-6 to omega-3 ratio, and the odds of T2DM.

Methods

Our research involved a cross-sectional analysis of data from the Ravansar Non-Communicable Disease (RaNCD) cohort. We evaluated their dietary habits using a comprehensive 118-item food frequency questionnaire (FFQ). To determine the aforementioned association, we employed logistic regression analysis to calculate odds ratios (OR) and 95% confidence intervals (CIs).

Results

The prevalence of T2DM among 8744 qualified participants was 751 (8.6%). After considering all the possible factors that could affect the outcome, high dietary omega-3 intake was associated with a 58% lower likelihood of T2DM (OR: 0.42; 95% CI: 0.32, 0.56; P-trend: <0.001). In contrast, participants at the fourth quartile of the dietary omega 6 to omega 3 FA ratio had a higher odd of T2DM (OR: 1.42; 95%CI: 1.11, 1.84; P-trend: 0.01). Nevertheless, there was no significant connection between the highest and lowest quartile of dietary omega-6 intake (OR: 0.91; 95% CI: 0.71, 1.17; P-trend: 0.80).

Conclusion

According to the study, consuming omega-3 fatty acids through diet was linked with lower odds of type 2 diabetes. Conversely, an elevated omega-6 to omega-3 ratio was associated with a greater likelihood of T2DM.
Literature
1.
go back to reference Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.CrossRefPubMed Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.CrossRefPubMed
2.
go back to reference Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of Diabetes 2017. J Diabetes Res 2018, 2018:3086167. Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of Diabetes 2017. J Diabetes Res 2018, 2018:3086167.
3.
go back to reference Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, Kashif M, Shahzeen F. Tayyab A, Moazzam Khan MS: Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus 2023, 15(9). Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, Kashif M, Shahzeen F. Tayyab A, Moazzam Khan MS: Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus 2023, 15(9).
4.
go back to reference Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS ONE. 2018;13(3):e0194127.CrossRefPubMedPubMedCentral Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS ONE. 2018;13(3):e0194127.CrossRefPubMedPubMedCentral
5.
go back to reference Standl E, Khunti K, Hansen TB, Schnell O. The global epidemics of diabetes in the 21st century: current situation and perspectives. Eur J Prev Cardiol. 2019;26(2suppl):7–14.CrossRefPubMed Standl E, Khunti K, Hansen TB, Schnell O. The global epidemics of diabetes in the 21st century: current situation and perspectives. Eur J Prev Cardiol. 2019;26(2suppl):7–14.CrossRefPubMed
6.
go back to reference Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133(2):187–225.CrossRefPubMedPubMedCentral Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133(2):187–225.CrossRefPubMedPubMedCentral
7.
go back to reference Ponnampalam EN, Sinclair AJ, Holman BW. The sources, synthesis and biological actions of omega-3 and omega-6 fatty acids in red meat: an overview. Foods. 2021;10(6):1358.CrossRefPubMedPubMedCentral Ponnampalam EN, Sinclair AJ, Holman BW. The sources, synthesis and biological actions of omega-3 and omega-6 fatty acids in red meat: an overview. Foods. 2021;10(6):1358.CrossRefPubMedPubMedCentral
8.
go back to reference Saini RK, Keum Y-S. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance—A review. Life Sci. 2018;203:255–67.CrossRefPubMed Saini RK, Keum Y-S. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance—A review. Life Sci. 2018;203:255–67.CrossRefPubMed
9.
go back to reference Jiang H, Wang L, Wang D, Yan N, Li C, Wu M, Wang F, Mi B, Chen F, Jia W. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality. Clin Nutr. 2022;41(8):1798–807.CrossRefPubMed Jiang H, Wang L, Wang D, Yan N, Li C, Wu M, Wang F, Mi B, Chen F, Jia W. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality. Clin Nutr. 2022;41(8):1798–807.CrossRefPubMed
10.
go back to reference Qian F, Ardisson Korat AV, Imamura F, Marklund M, Tintle N, Virtanen JK, Zhou X, Bassett JK, Lai H, Hirakawa Y. n-3 fatty acid biomarkers and incident type 2 diabetes: an individual participant-level pooling project of 20 prospective cohort studies. Diabetes Care. 2021;44(5):1133–42.CrossRefPubMedPubMedCentral Qian F, Ardisson Korat AV, Imamura F, Marklund M, Tintle N, Virtanen JK, Zhou X, Bassett JK, Lai H, Hirakawa Y. n-3 fatty acid biomarkers and incident type 2 diabetes: an individual participant-level pooling project of 20 prospective cohort studies. Diabetes Care. 2021;44(5):1133–42.CrossRefPubMedPubMedCentral
11.
go back to reference Wu JH, Marklund M, Imamura F, Tintle N, Korat AVA, De Goede J, Zhou X, Yang W-S, de Oliveira Otto MC, Kröger J. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol. 2017;5(12):965–74.CrossRefPubMedPubMedCentral Wu JH, Marklund M, Imamura F, Tintle N, Korat AVA, De Goede J, Zhou X, Yang W-S, de Oliveira Otto MC, Kröger J. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol. 2017;5(12):965–74.CrossRefPubMedPubMedCentral
12.
go back to reference Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, Djousse L, Hu FB, Mozaffarian D. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. 2012;107(S2):S214–27.CrossRefPubMedPubMedCentral Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, Djousse L, Hu FB, Mozaffarian D. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. 2012;107(S2):S214–27.CrossRefPubMedPubMedCentral
13.
go back to reference Neuenschwander M, Barbaresko J, Pischke CR, Iser N, Beckhaus J, Schwingshackl L, Schlesinger S. Intake of dietary fats and fatty acids and the incidence of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective observational studies. PLoS Med. 2020;17(12):e1003347.CrossRefPubMedPubMedCentral Neuenschwander M, Barbaresko J, Pischke CR, Iser N, Beckhaus J, Schwingshackl L, Schlesinger S. Intake of dietary fats and fatty acids and the incidence of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective observational studies. PLoS Med. 2020;17(12):e1003347.CrossRefPubMedPubMedCentral
14.
go back to reference Simopoulos AP. Evolutionary aspects of the dietary omega-6/omega-3 fatty acid ratio: medical implications. Evolutionary Think Medicine: Res Policy Pract 2016:119–34. Simopoulos AP. Evolutionary aspects of the dietary omega-6/omega-3 fatty acid ratio: medical implications. Evolutionary Think Medicine: Res Policy Pract 2016:119–34.
15.
go back to reference Chaves H, Singh RB, Khan S, Wilczynska A, Takahashi T. High omega-6/omega-3 fatty acid ratio diets and risk of noncommunicable diseases: is the tissue, the main issue? The role of functional food security in global health. edn.: Elsevier; 2019. pp. 217–59. Chaves H, Singh RB, Khan S, Wilczynska A, Takahashi T. High omega-6/omega-3 fatty acid ratio diets and risk of noncommunicable diseases: is the tissue, the main issue? The role of functional food security in global health. edn.: Elsevier; 2019. pp. 217–59.
16.
go back to reference Brown TJ, Brainard J, Song F, Wang X, Abdelhamid A, Hooper L. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. bmj 2019, 366. Brown TJ, Brainard J, Song F, Wang X, Abdelhamid A, Hooper L. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. bmj 2019, 366.
17.
go back to reference Ericson U, Hellstrand S, Brunkwall L, Schulz CA, Sonestedt E, Wallström P, Gullberg B, Wirfält E, Orho-Melander M. Food sources of fat may clarify the inconsistent role of dietary fat intake for incidence of type 2 diabetes. Am J Clin Nutr. 2015;101(5):1065–80.CrossRefPubMed Ericson U, Hellstrand S, Brunkwall L, Schulz CA, Sonestedt E, Wallström P, Gullberg B, Wirfält E, Orho-Melander M. Food sources of fat may clarify the inconsistent role of dietary fat intake for incidence of type 2 diabetes. Am J Clin Nutr. 2015;101(5):1065–80.CrossRefPubMed
18.
go back to reference Brostow DP, Odegaard AO, Koh WP, Duval S, Gross MD, Yuan JM, Pereira MA. Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2011;94(2):520–6.CrossRefPubMedPubMedCentral Brostow DP, Odegaard AO, Koh WP, Duval S, Gross MD, Yuan JM, Pereira MA. Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2011;94(2):520–6.CrossRefPubMedPubMedCentral
19.
go back to reference Alhazmi A, Stojanovski E, McEvoy M, Garg ML. Macronutrient intake and type 2 diabetes risk in middle-aged Australian women. Results from the Australian longitudinal study on women’s Health. Public Health Nutr. 2014;17(7):1587–94.CrossRefPubMed Alhazmi A, Stojanovski E, McEvoy M, Garg ML. Macronutrient intake and type 2 diabetes risk in middle-aged Australian women. Results from the Australian longitudinal study on women’s Health. Public Health Nutr. 2014;17(7):1587–94.CrossRefPubMed
20.
go back to reference Pasdar Y, Najafi F, Moradinazar M, Shakiba E, Karim H, Hamzeh B, Nelson M, Dobson A. Cohort Profile: Ravansar Non-communicable Disease cohort study: the first cohort study in a kurdish population. Int J Epidemiol. 2019;48(3):682–f683.CrossRefPubMed Pasdar Y, Najafi F, Moradinazar M, Shakiba E, Karim H, Hamzeh B, Nelson M, Dobson A. Cohort Profile: Ravansar Non-communicable Disease cohort study: the first cohort study in a kurdish population. Int J Epidemiol. 2019;48(3):682–f683.CrossRefPubMed
21.
go back to reference Hamzeh B, Bagheri A, Pasdar Y, Darbandi M, Rezaeian S, Najafi F, Moradinazar M. Predicting metabolic syndrome by anthropometric measures among adults 35–65 years in the west of Iran; a cross sectional study from an Iranian RaNCD cohort data. Diabetes Metab Syndr. 2020;14(5):1293–8.CrossRefPubMed Hamzeh B, Bagheri A, Pasdar Y, Darbandi M, Rezaeian S, Najafi F, Moradinazar M. Predicting metabolic syndrome by anthropometric measures among adults 35–65 years in the west of Iran; a cross sectional study from an Iranian RaNCD cohort data. Diabetes Metab Syndr. 2020;14(5):1293–8.CrossRefPubMed
22.
go back to reference Shakiba E, Najafi F, Pasdar Y, Moradinazar M, Navabi J, Shakiba MH, Bagheri A. A prospective cohort study on the association between dietary fatty acids intake and risk of hypertension incident. Sci Rep. 2023;13(1):21112.CrossRefPubMedPubMedCentral Shakiba E, Najafi F, Pasdar Y, Moradinazar M, Navabi J, Shakiba MH, Bagheri A. A prospective cohort study on the association between dietary fatty acids intake and risk of hypertension incident. Sci Rep. 2023;13(1):21112.CrossRefPubMedPubMedCentral
23.
go back to reference Azar M, Sarkisian E. Food composition table of Iran: National Nutrition and Food Research Institute. Shaheed Beheshti University, Tehran; 1980. Azar M, Sarkisian E. Food composition table of Iran: National Nutrition and Food Research Institute. Shaheed Beheshti University, Tehran; 1980.
24.
go back to reference Safari-Faramani R, Rajati F, Tavakol K, Hamzeh B, Pasdar Y, Moradinazar M, Najafi F. Prevalence, awareness, treatment, control, and the associated factors of diabetes in an Iranian Kurdish population. Journal of diabetes research 2019. Safari-Faramani R, Rajati F, Tavakol K, Hamzeh B, Pasdar Y, Moradinazar M, Najafi F. Prevalence, awareness, treatment, control, and the associated factors of diabetes in an Iranian Kurdish population. Journal of diabetes research 2019.
26.
go back to reference Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65(4):S1220–8.CrossRef Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65(4):S1220–8.CrossRef
27.
go back to reference Qian F, Ardisson Korat AV, Imamura F, Marklund M, Tintle N, Virtanen JK, Zhou X, Bassett JK, Lai H, Hirakawa Y, et al. n-3 fatty acid biomarkers and incident type 2 diabetes: an individual participant-level Pooling Project of 20 prospective cohort studies. Diabetes Care. 2021;44(5):1133–42.CrossRefPubMedPubMedCentral Qian F, Ardisson Korat AV, Imamura F, Marklund M, Tintle N, Virtanen JK, Zhou X, Bassett JK, Lai H, Hirakawa Y, et al. n-3 fatty acid biomarkers and incident type 2 diabetes: an individual participant-level Pooling Project of 20 prospective cohort studies. Diabetes Care. 2021;44(5):1133–42.CrossRefPubMedPubMedCentral
28.
go back to reference Hu M, Fang Z, Zhang T, Chen Y. Polyunsaturated fatty acid intake and incidence of type 2 diabetes in adults: a dose response meta-analysis of cohort studies. Diabetol Metab Syndr. 2022;14(1):34.CrossRefPubMedPubMedCentral Hu M, Fang Z, Zhang T, Chen Y. Polyunsaturated fatty acid intake and incidence of type 2 diabetes in adults: a dose response meta-analysis of cohort studies. Diabetol Metab Syndr. 2022;14(1):34.CrossRefPubMedPubMedCentral
29.
go back to reference Chen C, Yang Y, Yu X, Hu S, Shao S. Association between omega-3 fatty acids consumption and the risk of type 2 diabetes: a meta‐analysis of cohort studies. J Diabetes Invest. 2017;8(4):480–8.CrossRef Chen C, Yang Y, Yu X, Hu S, Shao S. Association between omega-3 fatty acids consumption and the risk of type 2 diabetes: a meta‐analysis of cohort studies. J Diabetes Invest. 2017;8(4):480–8.CrossRef
30.
go back to reference Sepidarkish M, Rezamand G, Qorbani M, Heydari H, Estêvão MD, Omran D, Morvaridzadeh M, Roffey DM, Farsi F, Ebrahimi S. Effect of omega-3 fatty acids supplementation on adipokines: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2022;62(27):7561–75.CrossRefPubMed Sepidarkish M, Rezamand G, Qorbani M, Heydari H, Estêvão MD, Omran D, Morvaridzadeh M, Roffey DM, Farsi F, Ebrahimi S. Effect of omega-3 fatty acids supplementation on adipokines: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2022;62(27):7561–75.CrossRefPubMed
31.
go back to reference Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105–15.CrossRefPubMed Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105–15.CrossRefPubMed
32.
go back to reference Bayram SŞ, Kızıltan G. The role of Omega-3 polyunsaturated fatty acids in diabetes Mellitus Management: a narrative review. Curr Nutr Rep 2024:1–25. Bayram SŞ, Kızıltan G. The role of Omega-3 polyunsaturated fatty acids in diabetes Mellitus Management: a narrative review. Curr Nutr Rep 2024:1–25.
33.
go back to reference Kumar M, Pal N, Sharma P, Kumawat M, Sarma DK, Nabi B, Verma V, Tiwari RR, Shubham S, Arjmandi B. Omega-3 fatty acids and their interaction with the gut microbiome in the prevention and amelioration of type-2 diabetes. Nutrients. 2022;14(9):1723.CrossRefPubMedPubMedCentral Kumar M, Pal N, Sharma P, Kumawat M, Sarma DK, Nabi B, Verma V, Tiwari RR, Shubham S, Arjmandi B. Omega-3 fatty acids and their interaction with the gut microbiome in the prevention and amelioration of type-2 diabetes. Nutrients. 2022;14(9):1723.CrossRefPubMedPubMedCentral
34.
go back to reference Shetty SS, Suchetha Kumari N, Varadarajan R. The ratio of omega-6/omega-3 fatty acid: implications and application as a marker to diabetes. Biomarkers in diabetes. edn.: Springer; 2022. pp. 449–67. Shetty SS, Suchetha Kumari N, Varadarajan R. The ratio of omega-6/omega-3 fatty acid: implications and application as a marker to diabetes. Biomarkers in diabetes. edn.: Springer; 2022. pp. 449–67.
Metadata
Title
The relationship of dietary omega-3 fatty acid and omega-6 to omega-3 ratio intake and likelihood of type 2 diabetes in a cross-sectional study
Authors
Ebrahim Shakiba
Yahya Pasdar
Farzaneh Asoudeh
Farid Najafi
Amir Saber
Mohammad Hossein Shakiba
Amir Bagheri
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Type 2 Diabetes
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01787-y

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more